References
Mikkelsen AL. Strategies in human in-vitro maturation and their clinical outcome. Reprod Biomed Online. 2005;10(5):593–9.
Le Du A, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod. 2005;20(2):420–4.
Zhao JZ, Zhou W, Zhang W, Ge HS, Huang XF, Lin JJ. In vitro maturation and fertilization of oocytes from unstimulated ovaries in infertile women with polycystic ovary syndrome. Fertil Steril. 2009;91(6):2568–71.
Son WY, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Updat. 2010;16(6):675–79.
De Vos M, Ortega-Hrepich C, Albuz FK, Guzman L, Polyzos NP, Smitz J, et al. Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2011;96(4):860–4.
Fadini R, Dal Canto MB, Renzini MM, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online. 2009;19(3):343–51.
Lin YH, Hwang JL, Huang LW, Mu SC, Seow KM, Chung J, et al. Combination of FSH priming and hCG priming for in–vitro maturation of human oocytes. Hum Reprod. 2003;18(8):1632–6.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
Eftekhar M, Karimzadeh MA. In vitro maturation for infertile women with PCOS. Iran J Reprod Med. 2007;5(22):28.
Lin YH, Hwang JL. In vitro maturation of human oocytes. Taiwan J Obstet Gynecol. 2006;45(2):95–9.
Reinblatt SL, Son WY, Shalom-Paz E, Holzer H. Controversies in IVM. J Assist Reprod Genet. 2011;28(6):525–30.
Elizur SE, Son WY, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17 [beta]-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril. 2009;92(3):907–12.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
We believe that delayed FSH priming until endometrial thickness reaches 7 mm by endogenous estrogen may be an appropriate intervention for endometrial preparation in PCOS cases undergoing IVM.
Rights and permissions
About this article
Cite this article
Eftekhar, M., Khalili, M.A., Aflatoonian, A. et al. Successful pregnancy following a novel endometrial preparation in a PCOS patient undergoing IVM: a case report. J Assist Reprod Genet 29, 335–336 (2012). https://doi.org/10.1007/s10815-012-9723-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-012-9723-0